← All diseases
Cancer
Liver cancer
Do you want to receive a message when there is new research about Liver cancer? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence above each publication explains what was studied — and you'll be notified as soon as new research on Liver cancer is available. View what Premium costs.
Publications (2771)
- Prediction of postoperative early recurrence and response to adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma with microvascular invasion after hepatectomy: a multicenter study. (2026/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role of traditional Chinese medicine in ferroptosis of liver cancer: Focus on signaling pathways. (2026/06/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. How should we interpret the use of vonoprazan and proton pump inhibitors during immunotherapy for hepatocellular carcinoma? (2026/06/01) ♡
- Therapeutic and toxicity targets for Euphorbia Kansui L. in treating hepatocellular carcinoma ascites revealed by ingredients pattern analysis accompanying vinegar processing. (2026/06/01) ♡
- Integrated analysis of network pharmacology and multi-omics reveals the mechanisms of Zuogui Jiangtang Qinggan formula ameliorates MASLD via fatty acid metabolic reprogramming. (2026/06/01) ♡
- Evaluation of antitumor activity and targeted enrichment of bioactive compounds from Dendrobium fimbriatum hook. (2026/06/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Tumor regression and neurological recovery in paraplegia from POLD1-mutated hepatocellular carcinoma treated with targeted immunotherapy and electroacupuncture. (2026/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Aflatoxin B1 and food safety: Mechanisms of action associated to Hepatocellular Carcinoma. (2026/06/01) ♡
- Artificially Sweetened and Sugar-Sweetened Beverage Intake and Risk of Liver Cancer. (2026/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management. (2026/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Dietary Polyphenols and Selected Nutraceuticals in Hepatocellular Carcinoma: Mechanistic Insights, Translational Evidence, and Clinical Prospects. (2026/05/31) ♡
- Prognostic value of inflammation-immunity-nutrition score in patients with cancers. (2026/05/30) ♡
- Alhagi honey polysaccharide ameliorates carbon tetrachloride-induced liver fibrosis via modulating the gut microbiota-liver metabolism axis. (2026/05/28) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Distinct and shared synergistic effects of high-fat and high-iron diets on liver tumorigenesis and transcriptomic remodeling in mice. (2026/05/27) ♡
- Epidemiological, clinical and therapeutic profile of hepatocellular carcinoma in Toamasina Madagascar. (2026/05/26) ♡
- Schisandrin A suppresses hepatocellular carcinoma and sensitizes to sorafenib via modulating retinol metabolism. (2026/05/25) ♡
- Eupalinolide B ameliorates liver fibrosis by targeting PKCα to suppress the AKT/mTOR axis in hepatic stellate cells. (2026/05/23) ♡
- Multiple Aflatoxins Drive Cumulative Dietary Exposure and Hepatocellular Carcinoma Risk: An Age-Stratified Study in Guangzhou, China. (2026/05/22) ♡
- Mechanistic insights into the anti-metastatic effects of calycosin from Ruanjianhugan tablets on hepatocellular carcinoma via CHEK1 targeting: a network analysis. (2026/05/21) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Shenling Baizhu San Ameliorates MASH and Associated Depression-like Behavior in Mice by Impacting Gut Microbiota and Carbohydrate Enzymes. (2026/05/21) ♡
- Nanomaterial-based strategies to overcome sorafenib resistance in hepatocellular carcinoma: from mechanistic insights to translational applications. (2026/05/20) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Elucidating the Molecular Mechanisms of Angelica sinensis Against Hepatocellular Carcinoma Through Network Pharmacology, in silico Molecular Docking, and in vitro Validation. (2026/05/20) ♡
- Modulation of mRNA Expression of Biomarkers in the UPR-PERK Pathway by Ellagic Acid in Metabolic Dysfunction-Associated Fatty Liver Disease. (2026/05/17) ♡
- Integrating Network Pharmacology and Experimental Validation to Elucidate the Role of Huaier in Attenuating Liver Fibrosis via the AKT Signalling Pathway. (2026/05/15) ♡
- Preoperative prediction of early recurrence and microvascular invasion in hepatocellular carcinoma using conventional ultrasound, elastography, and clinical nutritional indicators: a radiomics-based study. (2026/05/15) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. First-line immunotherapy for advanced hepatocellular carcinoma: a network meta-analysis of randomized trials with overall and HBV/HCV-stratified efficacy and safety. (2026/05/14) ♡
- Assessment of GALAD score as a diagnostic and prognostic factor of de novo hepatitis C-related hepatocellular carcinoma post treatment with direct-acting antivirals. (2026/05/11) ♡
- Untargeted metabolomics and in-house database analysis reveal differences between Elephantopus scaber L. and Elephantopus tomentosus L. (2026/05/10) ♡
- RETRACTION: Herbal Compound "Songyou Yin" Renders Hepatocellular Carcinoma Sensitive to Oxaliplatin through Inhibition of Stemness. (2026/05/08) ♡
- FDFT1 Acts as a Negative Regulator of Autophagy by Modulating AMPK-ULK1 Signaling in Hepatocellular Carcinoma Cells. (2026/05/01) ♡
- Integrating UHPLC-Q-TOF-MS, Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations to Reveal the Potential Mechanisms of Yiguanjian Decoction in Treating Liver Cancer. (2026/05/01) ♡
- Transcutaneous Electrical Acupoint Stimulation for Opioid Tolerance in Hepatocellular Carcinoma and Proteomics Analysis: A Randomized Controlled Trial Protocol. (2026/04/23) ♡
- Precision mitochondrial reprogramming via a ROS-amplifying Pt(IV) nanoplatform potentiates tri-modal therapy to overcome Pt resistance in HCC. (2026/04/22) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Navigating the Labyrinth of Hepatocellular Carcinoma: Leveraging AI/ML for Precision Oncology. (2026/04/22) ♡
- Contemporary Tumor Histology Grouping for Survival Prediction of Patients With Metastatic Long-bone Disease Undergoing Surgery. (2026/04/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Occult hepatitis B infection. (2026/04/14) ♡
- High expression of USP15 affects tumor progression and immune infiltration in hepatocellular carcinoma. (2026/04/08) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The Central Qi theory in traditional Chinese medicine: Gut microbiota modulation as a strategic target for hepatocellular carcinoma therapy. (2026/04/06) ♡
- Alleviation of adverse effects associated with α-glucosidase inhibitors by Ocimum basilicum L., Matricaria chamomilla L., and Salvia officinalis L. reveals novel selective inhibition of Bacillus α-glucosidase by acarbose. (2026/04/06) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Progress in research on the hepatoprotective effects of C-21 steroidal glycosides from Baishouwu. (2026/04/06) ♡
- Multi-omics identification of therapeutic targets of compound sappan decoction in hepatocellular carcinoma. (2026/04/02) ♡
- Liver transplantation for hepatocellular carcinoma arising in non-cirrhotic liver: a national-wide retrospective cohort study with propensity score matching analysis in China. (2026/04/01) ♡
- Treatment guidelineiAn official agreement between doctors about how this disease should be treated. This is not a single study but the conclusion of an entire medical field. AASLD ISDA Practice Guideline on treatment of chronic hepatitis B. (2026/04/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Higher consumption of ultra-processed foods and long-term risk of metabolic dysfunction-associated steatotic liver disease and primary liver cancer: A meta-analysis of preliminary evidence. (2026/04/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Novel biomarkers for alcohol-associated liver disease and their implications across clinical settings. (2026/04/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Negative 68Ga-FAPI-04 Uptake on PET/CT in HNF-1α-mutated Hepatocellular Adenoma: A Distinctive Feature for Differentiating From Hepatocellular Carcinoma. (2026/04/01) ♡
- PHENO-RAG: An artificial intelligence tool for guideline-informed management decisions in hepatocellular carcinoma. (2026/04/01) ♡
- Radiation-induced lymphopenia is associated with survival in patients with hepatocellular carcinoma treated with stereotactic body radiotherapy. (2026/04/01) ♡
- A liver gene signature links liver cancer risk in chronic viral hepatitis to intrahepatic IgA plasma cells. (2026/04/01) ♡
- EREG-secreting THBS1(+) tissue monocytes are recruited by C5a to promote rapid liver regeneration in patients and mice during the ALPPS procedure. (2026/04/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.